 
- 积分
- 306
- 威望
- 306
- 包包
- 3648
|

Nature Communications 1 , Article number: 71 doi:10.1038/ncomms1074
) w" e; U$ ]$ H- a
7 ^+ _# `+ O2 N2 M% ]3 K, nNon-muscle myosin II regulates survival threshold of pluripotent stem cells
# T% [2 E" h$ {' Y( P* k7 j3 p3 J5 r0 H/ Z/ v( v
Andrea Walker, Hua Su,Mary Anne Conti,Nicole Harb,Robert S. Adelstein& Noboru Sato
$ N% L7 }* G, H6 n
9 A3 m$ X2 {% \0 V5 b- ~! s5 OHuman pluripotent stem (hPS) cells such as human embryonic stem (hES) and induced pluripotent stem (hiPS) cells are vulnerable under single cell conditions, which hampers practical applications; yet, the mechanisms underlying this cell death remain elusive. In this paper, we demonstrate that treatment with a specific inhibitor of non-muscle myosin II (NMII), blebbistatin, enhances the survival of hPS cells under clonal density and suspension conditions, and, in combination with a synthetic matrix, supports a fully defined environment for self-renewal. Consistent with this, genetically engineered mouse embryonic stem cells lacking an isoform of NMII heavy chain (NMHCII), or hES cells expressing a short hairpin RNA to knock down NMHCII, show greater viability than controls. Moreover, NMII inhibition increases the expression of self-renewal regulators Oct3/4 and Nanog, suggesting a mechanistic connection between NMII and self-renewal. These results underscore the importance of the molecular motor, NMII, as a novel target for chemically engineering the survival and self-renewal of hPS cells |
|